Hypolipidemic effect of different extracts of Clerodendron colebrookianum Walp in normal and high-fat diet fed rats

Journal of Ethnopharmacology

Volumn 90, Issue 1, 2004, Pages 63-68

  Devi, Rajlakshmi ^a   Sharma, D K ^b  

^a INSTITUTE OF ADVANCED STUDY IN SCIENCE AND TECHNOLOGY   (India)

^b GAUHATI UNIVERSITY   (India)

Author keywords

Cardioprotection; Clerodendron colebrookianum; Hypolipidemic

Indexed keywords

CHOLESTEROL; CLERODENDRON COLEBROOKIANUM EXTRACT; HERBACEOUS AGENT; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PLANT EXTRACT; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; CLERODENDRON COLEBROOKIANUM; CONTROLLED STUDY; DIET; DRUG EFFECT; HEART PROTECTION; HYPOLIPEMIA; LIPID BLOOD LEVEL; LIPID DIET; MALE; MEDICINAL PLANT; NONHUMAN; RAT; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0347123328     PISSN: 03788741     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jep.2003.09.022     Document Type: Article

References (31)

1. Bainton D., Miller N.E., Botton C.H., Yarnell J.W.G., Suretman P.M., Baker I.A., Lewis B., Elwood P.C. Plasma triglycerides and high density lipoprotein cholesterol as predictors of ischemic heart disease in British man. British Heart Journal. 68:1992;60-66.
2. Banerjee, H.N., 1936. Clerodin from Clerodendron infortunatum. Science and Culture 2, 163.
3. Bordoloi, B., Borthakur, S.K., 1997. Botanical identity of "Phuinum" a folk remedy for hypertension. BKEBR XVIII (1-2) Central Council for Research in Ayurvedic & Siddha, New Delhi, pp 18-29.
4. De Graat J., De Sauvage N.P.R., Van Dam M., Belsey E.M., Kastelein J.J., Haydn P.P., Stalenhoef A.F. Consumption of tall oil-derived phytosterol in a chocolate matrix significantly decrease plasma total and low-density lipoprotein-cholesterol levels. British Journal of Nutrition. 88:2002;479-488.
5. El-Hazmi M.A., Warsy A.S. Evaluation of serum cholesterol and triglyceride levels in 1-6-year-old Saudi children. Journal of Tropical Pediatrics. 47:2001;181-185.
6. Faris, E.J., 1950. Care and Breeding of Laboratory Animals, vol. XVI. John Wiley and Sons, New York, pp. 66-67.
7. Friedwald's W.T., Levy I.R., Friedrickson S.D. Estimation of concentration of low density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clinical Chemistry. 18:1972;499-502.
8. Fossati, P., Prencipe, L., 1982. Clinical Chemistry 28, 2077.
9. Goldstein J.L., Schrott H.G., Hazzard W.R., Bierman E.L., Motulsky A.G. Hyperlipidaemia in coronary heart disease 11. Genetic analysis of lipid levels in 176 families and deliniation of a new inherited disorders, combined hyperlipidaemia. Journal of Clinical Investigation. 52:1973;1544-1568.
10. Goswami P., Kotoky J., Chern Z., Lu Y. A sterol glycosides from leaves of Clerodendron colebrookianum. Phytochemistry. 41:1995;279-281.
11. Gupta R., Gupta H.P., Kumar N., Joshi A.K., Gupta V.P. Lipoprotein lipids and prevelence of hyperlipidaemia in rural India. Journal of Cardiovascular Risk. 1:1994;179-183.
12. Gupta R., Kaul V., Prakash H. Profiles of cholesterol and other lipids in Indian men. Indian Heart Journal. 47:1995;636.
13. Harrison D., Kathy K.G., Hornig B., Drexler H. Role of oxidative stress in atherosclerosis. American Journal of Cardiology. 91:2003;7A-11A.
14. Henry, R.J.U.M., 1974. Clinical Chemistry, 2nd ed. Harper and Row Publishers, New York, pp. 1440u, 1443.
15. Hui Yang, Jia Wang, Ai-Jun Hou, Yun-Pin Guo, Zhong-Wen Lin, Han-Dong Sun, 2000. New steroids from Clerodendron colebrookianum. Fitopterapia 71, 641-648.
16. Jacke G., Rimpler H. Distribution of iridoid glycosides in Clerodondron species. Phytochemistry. 22:1983;1729-1734.
17. Joshi K.C., Singh P., Mehra A. Chemical investigation of the roots of different Clerodendron species. Planta Medica. 37:1979;64.
18. Lees A.M., Mok H.Y.I., Lees R.S., Mc. Cluskey M.A., Grundy S.M. Plant sterol as cholesterol-lowering agent: clinical trials in patients with hypercholesterolemia and studies of sterol balance. Atherosclerosis. 28:1977;325-338.
19. Lipid Research Clinics Program, 1984a. The lipid research clinics coronary primary prevention trial results: 1. Reduction in incidence of coronary heart disease. Journal of American Medical Association 251, 251-364.
20. Lipid Research Clinics Program, 1984b. The lipid research clinics coronary primary prevention trial results: 11. The relationship of reduction in incidence of coronary heart disease to cholesterol lowering. Journal of American Medical Association 251, 365-374.
21. Mattson F.H., Grundy S.M., Crouse J.R. Optimizing the effect of plant sterols on cholesterol absorption in man. American Journal of Clinical Nutrition. 35:1982;697-700.
22. Mc Gown., M.W., Artiss J.D., Strandbergh, D.R., Zak, B., 1983. Clinical Chemistry 29, 538.
23. Nath, S.C., Bordoloi, D.N., 1988. Medicinal uses of Clerodendron colebrookianum Walp. Himalaya: Man and Nature, 13-14.
24. Nath S.C., Bordoloi D.N. Clerodendron colebrookianum, a folk remedy for the treatment of hypertension in north eastern India. International Journal of Pharmacology. 29:1991;127-129.
25. National Cholesterol Education Program Expert Panel, 1994. Second report of the expert panel on detection, evaluation and treatment of high blood cholesterol in adults. Circulation 89, 1329-1450.
26. Pollak, O.J., Kritchevsky, D., 1981. Sitosterol. Monograph Athersclerosis 10, 1-219.
27. Ramakrishnan, S., 1994. Biochemistry Students' Manual, 1st ed. T.R. Publication, pp. 246-281.
28. Simons, L.A., 2002. Additive effect of plant sterol-ester margarine and cerivastatin in lowering low density lipoprotein cholesterol in primary hypercholesterolemia. American Journal of Cardiology 90, 737-740.
29. Singh M., Choudhury P.K., Sharma R.P., Jain S.P. Constituent of the leaves of the Clerodendron colebrookianum. Indian Journal of Chemistry. 34B:1995;753-754.
30. Temme, E.H., Van, H.P.G., Schouten, E.G., Kesteloot, H., 2002. Effect of a plant sterol-enriched spread on serum lipids and lipoproteins in mildly hypercholesterolaemic subjects. Acta Cardiology 57, 111-115.
31. Wilson P.W.F. High density lipoprotein, low density lipoprotein and coronary heart disease. American Journal of Cardiology. 66:1990;7A-10A.